Cronos Group, Inc. (CRON)
3.225
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
3.225
0.00 (0.00%)
After-Hours: 17:48
Cronos Group Market Cap : 1.196B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.194B |
| October 07, 2026 | 1.201B |
| October 06, 2026 | 1.218B |
| October 05, 2026 | 1.205B |
| October 02, 2026 | 1.196B |
| October 01, 2026 | 1.190B |
| September 30, 2026 | 1.223B |
| September 29, 2026 | 1.253B |
| September 28, 2026 | 1.264B |
| September 25, 2026 | 1.238B |
| September 24, 2026 | 1.231B |
| September 23, 2026 | 1.260B |
| September 22, 2026 | 1.272B |
| September 21, 2026 | 1.235B |
| September 18, 2026 | 1.242B |
| September 17, 2026 | 1.249B |
| September 16, 2026 | 1.220B |
| September 15, 2026 | 1.186B |
| September 14, 2026 | 1.199B |
| September 11, 2026 | 1.164B |
| September 10, 2026 | 1.171B |
| September 09, 2026 | 1.170B |
| September 08, 2026 | 1.181B |
| September 04, 2026 | 1.209B |
| September 03, 2026 | 1.209B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.201B |
| September 01, 2026 | 1.253B |
| August 31, 2026 | 1.249B |
| August 28, 2026 | 1.253B |
| August 27, 2026 | 1.257B |
| August 26, 2026 | 1.316B |
| August 25, 2026 | 1.301B |
| August 24, 2026 | 1.264B |
| August 21, 2026 | 1.227B |
| August 20, 2026 | 1.194B |
| August 19, 2026 | 1.220B |
| August 18, 2026 | 1.190B |
| August 17, 2026 | 1.168B |
| August 14, 2026 | 1.164B |
| August 13, 2026 | 1.171B |
| August 12, 2026 | 1.175B |
| August 11, 2026 | 1.142B |
| August 10, 2026 | 1.112B |
| August 07, 2026 | 1.149B |
| August 06, 2026 | 1.138B |
| August 05, 2026 | 1.008B |
| August 04, 2026 | 1.042B |
| August 03, 2026 | 1.065B |
| July 31, 2026 | 1.065B |
| July 30, 2026 | 1.087B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexaria Bioscience Corp. | 5.371M |
| Target Group, Inc. (Canada) | 0.3085M |
| InMed Pharmaceuticals, Inc. | 7.315M |
| XORTX Therapeutics, Inc. | 2.440M |
| NervGen Pharma Corp. | 183.56M |
Market Cap Related Metrics
| PE Ratio | 17.51 |
| PS Ratio | 6.863 |
| PEG Ratio | 0.0610 |
| Price to Book Value | 1.119 |
| Price to Free Cash Flow | 24.77 |
| Price | 3.225 |
| Earnings Yield | 5.71% |
| PEGY Ratio | 0.0610 |
| Normalized PE Ratio | 16.29 |